GENEVA/LONDON (Reuters) – The World Health Organization (WHO) should soon get results from clinical trials it is conducting of drugs that might be effective in treating COVID-19 patients, its Director-General Tedros Adhanom Ghebreyesus said on Friday.
“Nearly 5,500 patients in 39 countries have so far been recruited into the Solidarity trial,” he told a news briefing, referring to clinical studies the U.N. agency is conducting.
“We expect interim results within the next two weeks.”
Mike Ryan, head of the WHO’s emergencies program, said it would be unwise to predict when a vaccine could be ready against COVID-19, the respiratory disease caused by the novel coronavirus that has killed more than half a million people.
Source: Reuters
FINANCED BY
This project was funded in part through a U.S. Embassy grant. The opinions, findings, and conclusions or recommendations expressed herein are those of the implementers/authors and do not necessarily reflect those of the U.S. Government.
PARTNERS
